Acadia Pharmaceuticals (ACAD) is in the business of development and commercialization of small molecule drugs for the treatment of central nervous system disorders. This stock is trading up 10.8% at $13.40 in recent trading.
Today's Volume: 6.39 millionAverage Volume: 3.32 million Volume % Change: 222% >>5 Health Care Stocks Under $10 Ready to Rip Higher From a technical perspective, ACAD is screaming higher here right off some near-term support at $11.81 with heavy upside volume. This move is quickly pushing shares of ACAD within range of triggering a major breakout trade. That trade will hit if ACAD manages to take out its 52-week high at $13.92 with high volume. Traders should now look for long-biased trades in ACAD as long as it's trending above some near-term resistance levels at $13 or $12.50 and then once it sustains a move or close above its 52-week high at $13.92 with volume that hits near or above 3.32 million shares. If that breakout hits soon, then ACAD will set up to re-test or possibly take out its next major overhead resistance levels at $15 to $16.50.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts